High fear of cancer recurrence in Chinese newly diagnosed cancer patients by Luo, Xian et al.
fpsyg-11-01287 June 6, 2020 Time: 15:34 # 1
ORIGINAL RESEARCH




University of Turin, Italy
Reviewed by:
Rainer Leonhart,
University of Freiburg, Germany
Ingrid Banovic,









†These authors have contributed
equally to this work
Specialty section:
This article was submitted to
Psychology for Clinical Settings,
a section of the journal
Frontiers in Psychology
Received: 27 March 2020
Accepted: 15 May 2020
Published: 09 June 2020
Citation:
Luo X, Li W, Yang Y, Humphris G,
Zeng L, Zhang Z, Garg S, Zhang B
and Sun H (2020) High Fear
of Cancer Recurrence in Chinese
Newly Diagnosed Cancer Patients.
Front. Psychol. 11:1287.
doi: 10.3389/fpsyg.2020.01287
High Fear of Cancer Recurrence in
Chinese Newly Diagnosed Cancer
Patients
Xian Luo1†, Wengao Li1†, Yuan Yang1†, Gerald Humphris2,3, Lijuan Zeng4, Zijun Zhang5,
Samradhvi Garg6, Bin Zhang1* and Hengwen Sun7*
1 Department of Psychiatry, Southern Medical University Nanfang Hospital, Guangzhou, China, 2 School of Medicine,
University of St Andrews, St Andrews, United Kingdom, 3 Edinburgh Cancer Centre, Western General Hospital, Edinburgh,
United Kingdom, 4 Department of Organ Transplantation, Second Affiliated Hospital of Guangzhou Medical University,
Guangzhou, China, 5 CNSST Foundation New Zealand, Panmure, Auckland, New Zealand, 6 School of Health in Social
Science, University of Edinburgh, Edinburgh, United Kingdom, 7 Department of Radiotherapy, Cancer Center, Guangdong
Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
Background: Fear of cancer recurrence (FCR) is common among cancer patients and
of high clinical relevance. This study explores the prevalence and correlates of FCR in
Chinese newly diagnosed cancer population.
Methods: This is a multicentre, cross-sectional study that includes 996 patients with
mixed cancer diagnosis. All recently diagnosed patients completed a questionnaire
consisting of the following: Fear of Progression Questionnaire-Short Form (FoP-Q-
SF), General Anxiety Disorder Questionnaire (GAD-7), and Patient Health Questionnaire
(PHQ-9). Univariate analyses, multivariate logistic regression analyses, and structural
equation modeling (SEM) was performed to examine the association between tested
variables and FCR.
Results: Of the 996 patients, 643 (64.6%) reported high FCR (scored ≥ 34 in the FoP-
Q-SF). Chemotherapy (OR = 1.941), Childhood severe illness experience (OR = 2.802),
depressive (OR = 1.153), and anxiety (OR = 1.249) symptoms were positively associated
with high FCR, while higher monthly income (OR = 0.592) was negatively associated with
high FCR. SEM indicated that emotional disturbances (anxiety and depression) directly
influenced FCR, while emotional disturbances partly mediated the association between
personal monthly income and FCR.
Conclusion: High FCR is a frequently reported problem among newly diagnosed
cancer patients. Various factors increased the likelihood of the development of FCR.
Flexible psychological interventions are needed for patients with high FCR.
Keywords: cancer, Chinese, fear of recurrence, newly diagnosed, structural equation modeling
INTRODUCTION
Cancer is one of the important public health problems worldwide. Psychosocial concerns such as
anxiety, depression, and fear of cancer recurrence (FCR) are commonly seen in cancer patients
from diagnosis through survivorship (Zhao et al., 2014). FCR is often defined as: fear, worry, or
concern relating to the possibility that cancer will come back or progress (Lebel et al., 2016). FCR is
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a key unmet need among cancer patients (Simard et al.,
2013). It includes illness-related concerns, such as fear of
tumor recurrence or of ongoing functional decline with all
its biopsychosocial consequences (Goebel and Mehdorn, 2019).
It is suggested that FCR is a unique, independent, and
multidimensional construct distinct from anxiety, depression,
and distress, with its own profile and mechanisms (Simard
et al., 2010). Thus, it needs to be evaluated with specific
instruments and treated with specific targeted psychological
interventions (Simard and Savard, 2009; Thewes et al., 2012;
Tauber et al., 2019).
Previous studies indicated that around 24–40% of cancer
patients reported moderate to high levels of need for help
dealing with FCR (Hartl, 2003; Hodgkinson et al., 2007a,b). The
determinants and consequences of FCR have been preliminarily
addressed by several studies. A systematic review in 2013
reported that those who diagnosed at a young age, female, and
with higher education background were more likely to experience
FCR compared with their counterparts (Simard et al., 2013).
A new review by Fardell et al. reported that previous losses
(Zakowski et al., 1997), concurrent stressors (Mellon et al.,
2007), and uncertainty due to lack of information (Mishel et al.,
2005) maybe important additional variables to understand the
development and maintenance of clinically significant recurrence
fear (Fardell et al., 2016). In addition, recent meta-analyses have
revealed that mastectomy (Koch et al., 2013), radiotherapy (Yang
et al., 2016), and chemotherapy (Yang et al., 2017) were significant
predictors of higher FCR. Increased levels of FCR could be
dysfunctional and significantly influence an individual’s well-
being. It often coexists with high psychological distress and poor
Health-related Quality of Life (HRQoL). Patients with elevated
FCR are more likely to report anxiety, depressive, and insomnia
symptoms, and report more difficulties planning for the future.
FCR also negatively affects treatment adherence and may lead to
higher risk of mortality (DiMatteo et al., 2000; Greer et al., 2008;
Pinquart and Duberstein, 2010).
Psychological distress, such as FCR, is considered as the sixth
vital sign of a cancer patient’s well-being along with signs of
respiration, temperature, blood pressure, heart rate, and pain
(Bultz and Carlson, 2006). However, there are only limited
studies conducted in Chinese population using validated FCR
measurements. Sun et al. (2019) found that around 36% of
the Chinese adolescent and young adult patients experienced
dysfunctional level of FCR and Yang et al. (2018) reported
that life stress, childhood severe illness experience, anxiety,
depressive symptom, and passive personality were independently
predictive of higher FCR.
For newly diagnosed cancer patients, the days and weeks after
diagnosis could be overwhelming, scary and lonely. However,
inconclusive evidence was found of the association between FCR
and time since diagnosis (Simard et al., 2013). There is a paucity
of evidence regarding the unmet needs of newly diagnosed cancer
patients. These patients have unique biological and psychological
needs, therefore, more efforts should be made to provide better
insights into this population.
In the current study, we concentrated on Chinese newly
diagnosed cancer patients (≤6 months). Our aim was to assess
FIGURE 1 | Proposed mediation path model.
the prevalence and correlates of high FCR. Based on previous
theoretical framework and empirical evidence, the association
between sociodemographic/clinical variables, and FCR were
often conflictive. However, psychological/emotional variables
(such as stress, anxiety, and depression) were consistently
found to be risk factors of clinical levels of FCR (Chaturvedi
et al., 1996; Humphris et al., 2003; Llewellyn et al., 2008;
Thewes et al., 2013), and explained most of the variance in
FCR (Urbaniec et al., 2011; Yang et al., 2018). Researchers
suggested that anxiety and depression are causes of FCR rather
than consequences (Walburg et al., 2019). Moreover, several
sociodemographic/clinical variables, such as gender, financial
status, and prior depression history have been proved to be
risk factors for emotional disturbances (Yi and Syrjala, 2017).
Therefore, we hypothesized that: (1) psychological variables
(anxiety and depression) will be significantly associated with
high FCR; (2) psychological variables will mediate the association
between sociodemographic/clinical variable and FCR; and (3)
compared to sociodemographic/clinical variables, psychological
variables will have greater total effect on FCR (proposed
model in Figure 1).
MATERIALS AND METHODS
Setting and Participants
A cross-sectional study was conducted at three hospitals in
southern China from September 2018 to September 2019.
Patients were recruited consecutively from Department of
Oncology in Southern Medical University Nanfang Hospital,
Guangdong Provincial People’s Hospital, and Guangzhou
Women and Children’s Medical Centre. The criteria for inclusion
were: (1) age ≥ 18 years, (2) have a diagnosis of cancer within 6
months, (3) be able to read and write Mandarin or Cantonese; (4)
provide written informed consent. Participants were excluded if
they had severe physical and/or cognitive impairment.
Study Procedure
All potential participants who met all eligibility criteria were
asked whether they would agree to participate in the study. They
were approached in the waiting room by trained research nurses
who explained the study aim and procedure. Those who agreed to
participate were asked to read a personal information sheet then
requested to sign the written informed consent. On completion
of the consenting process the participant was given a set of
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standardized questionnaires, and returned to the research staff
immediately. This study was performed in accordance with the
Helsinki standard and approved by the local ethics committee
[Ref Nos: NFEC-2018-038 and 2018295H(R1)].
Instruments
Demographic and Clinical Characteristics
Demographic and clinical characteristics were collected by
a special-designed demographic details sheet. The collected
data included: current age, gender, marital status, education,
employment, personal income, type of cancer, primary treatment
(surgery, chemotherapy, and radiation treatment), family cancer
history, medical comorbidities, and childhood experience.
Childhood adversity experience and severe illness experience
were assessed by two Yes/No questions (Sun et al., 2019): (1) Have
you ever experienced any childhood adversity experience, such as
sexual abuse, bullying, traffic accident, or natural calamities? (2)
Have you ever experienced any childhood severe illness, such as
childhood cancer, or traumatic injury?
Fear of Cancer Recurrence (FCR)
Patient’s FCR were assessed by the 12-item Fear of Progression
Questionnaire (FoP-Q-SF) (Herschbach et al., 2005). This scale
has been successfully applied to samples of different cancer
patients (Mehnert et al., 2006, 2009; Melchior et al., 2013). The
item scores from 1 to 5 (never to very often), and the total
score ranges from 12 to 60. A score of 34 or above indicates
a dysfunctional level of recurrence fear (Herschbach et al.,
2010). The psychometric properties of the Chinese version of
FoP-Q-SF are satisfactory (Cronbach’s alpha = 0.883), and the
recommended cut-off value is 34 for Chinese cancer patients
(Wu et al., 2015).
Patient Health Questionnaire-9 Item (PHQ-9)
Patient’s depressive symptoms were assessed by the PHQ. It is
a 9-item self-report measure and is commonly used in medical
settings. Its items range from 0 to 3 (“not at all” to “nearly
everyday”), and a total score of 5 or more indicates depressive
symptoms (Kroenke et al., 2010). The Chinese version of PHQ-9
shows good psychometric properties, the Cronbach’s alpha is 0.89
(Chen et al., 2015).
General Anxiety Disorder Questionnaire-7 Item
(GAD-7)
The GAD is a 7-item self-report scale used to measure patient’s
anxiety symptoms. Response options are not at all, several days,
more than half the days, and nearly every day, rated from 0 to 3,
and a total score of 5 or more indicates anxiety symptoms (Spitzer
et al., 2006). The GAD-7 has been translated and well-validated in
Chinese language (internal consistency = 0.91) (Zheng, 2013).
Statistical Analyses
Statistical analyses were performed using SPSS version 24.0 and
Amos version 21.0. First, normal distribution assumptions were
examined by one-sample Kolmogorov-Smirnov test. Descriptive
statistics were used to describe all demographic and clinical
characteristics of the study sample and were summarized as mean
with standard deviation (SD), or frequency with percentage.
Variables between the two groups (low vs. high FCR) were
investigated using independent sample t-test, Chi-square test or
Mann-Whitney U test, as appropriate. Second, all variables that
were significant (alpha level = 0.05) in the univariate analyses
were further examined by multivariate logistic regression with
“enter” method. High FCR (low FCR was the reference category)
was the dependent variable, while those with significant group
differences in the above univariate analyses were entered as
independent variables.
Finally, independent predictors of high FCR in multivariate
logistic regression were further investigated by structural
equation modeling (SEM), employing maximum likelihood
parameter estimation, to examine the direct and indirect
association between tested variables and FCR. Within the
models, PHQ, GAD, and FCR variable was entered as
continuous variable, and a latent variable (a hidden unobserved
variable) of “emotional disturbances” was constructed to
reflect the level of depressive and anxiety symptoms (Zhang
et al., 2020). Spearman correlation analyses were conducted.
Three different pathways were tested: (1) the path from
sociodemographic/clinical variables to FCR; (2) the path form
psychological/emotional variables to FCR, and (3) the path
from sociodemographic/clinical variables to FCR mediated
by psychological/emotional variables (Figure 1). The χ2/df,
comparative fit index (CFI), normed-fit index (NFI), incremental
fit index (IFI), Tucker-Lewis index (TLI), and Root Mean Square
Error of Approximation (RMSEA) were considered as model fit
indices. A CFI, NFI, IFI, and TLI of higher than 0.90, RMSEA
of lower than 0.08 were indicative of good model fit (Hu and




A total of 1,219 patients were eligible and invited to participate.
Nine hundred and ninety-six (81.71%) cancer patients agreed
therefore were included in the current study. The age of
participants ranged from 20 to 90 years, with a mean age of 48.04
(SD = 11.71) years. Approximately 90% of the participants were
female, and most of them were married (85.5%), and diagnosed
with breast cancer (80.6%). Of the 996 patients, 353 (35.4%)
reported low FCR while the remaining 643 (64.6%) reported
high FCR. Additionally, 369 (37.0%) of the patients reported
depressive symptoms and 285 (28.6%) of them reported anxiety
symptoms. Patient’s basic characteristics are presented in Table 1.
Univariate Analyses
Univariate analyses revealed that high FCR was significantly
associated with patient’s age (P = 0.006), marital status
(P = 0.048), personal monthly income (P = 0.001), chemotherapy
(P = 0.008), Childhood severe illness experience (P = 0.015),
depressive (P < 0.001), and anxiety symptoms (P < 0.001).
Patients who were younger, single, received chemotherapy, had
depressive and anxiety symptoms tended to report high FCR
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TABLE 1 | Factors associated with fear of cancer recurrence (N = 996).
Variable Fear of cancer recurrence
Total (%) Low (%) High (%) X2 df P
Age
≤39 years 246 (24.7) 75 (21.2) 171 (26.6)
40–60 years 556 (55.8) 221 (62.6) 335 (52.1)
≥ 60 years 194 (19.5) 57 (16.1) 137 (21.3) 10.259 2 0.006
Gender
Male 98 (9.8) 35 (9.9) 63 (9.8)
Female 898 (90.2) 318 (90.1) 580 (90.2) 0.004 1 0.953
Cancer Type
Breast 803 (80.6) 291 (82.4) 512 (79.6)
Lung 109 (10.9) 39 (11.0) 70 (10.9)
Colorectal 84 (8.4) 23 (6.5) 61 (9.5) 2.614 2 0.271
Cancer Stage
Stage 1 67 (6.7) 24 (6.8) 43 (6.7)
Stage 2 345 (34.6) 113 (32.0) 232 (36.1)
Stage 3 507 (50.9) 187 (53.0) 320 (49.8)
Stage 4 77 (7.7) 29 (8.2) 48 (7.5) 1.720 3 0.632
Marital Status
Single 72 (7.2) 18 (5.1) 54 (8.4)
Married 852 (85.5) 301 (85.3) 551 (85.7)
Divorced 39 (3.9) 19 (5.4) 20 (3.1)
Widowed 33 (3.3) 15 (4.2) 18 (2.8) 7.886 3 0.048
Education Level
High school or below 655 (65.8) 227 (64.3) 428 (66.6)
Undergraduate 261 (26.2) 93 (26.3) 168 (26.1)
Postgraduate or above 80 (8.0) 33 (9.3) 47 (7.3) 1.360 2 0.507
Personal Monthly Income
Less than 3,000 RMB 461 (46.3) 135 (38.2) 326 (50.7)
3,000–5,000 RMB 258 (25.9) 98 (27.8) 160 (24.9)
5,001–10,000 RMB 196 (19.7) 86 (24.4) 110 (17.1)
More than 10,000 RMB 81 (8.1) 34 (9.6) 47 (7.3) 15.976 3 0.001
Surgery
No 88 (8.8) 36 (10.2) 52 (8.1)
Yes 908 (91.2) 317 (89.8) 591 (91.9) 1.261 1 0.261
Chemotherapy
No 116 (11.6) 54 (15.3) 62 (9.6)
Yes 880 (88.4) 299 (84.7) 581 (90.4) 7.083 1 0.008
Radiotherapy
No 124 (12.4) 51 (14.4) 73 (11.4)
Yes 872 (87.6) 302 (85.6) 570 (88.6) 2.002 1 0.157
Physical Comorbidity
No 338 (33.9) 112 (31.7) 226 (35.1)
Yes 658 (66.1) 241 (68.3) 417 (64.9) 1.189 1 0.276
Family Cancer History
No 742 (74.5) 271 (76.8) 471 (73.3)
Yes 254 (25.5) 82 (23.2) 172 (26.7) 1.486 1 0.233
Childhood Adversity Exp
No 952 (95.6) 341 (96.6) 611 (95.0)
Yes 44 (4.4) 12 (3.4) 32 (5.0) 1.343 1 0.247
Childhood Severe Illness Exp
No 945 (94.9) 343 (97.2) 602 (93.6)
Yes 51 (5.1) 10 (2.8) 41 (6.4) 5.890 1 0.015
M (SD) M (SD) M (SD) Z df P
Depression (PHQ score) 5.082 (4.878) 2.518 (2.933) 6.489 (5.153) −13.721a – <0.001
Anxiety (GAD score) 3.783 (4.263) 1.510 (2.420) 5.031 (4.533) −13.867a – <0.001
In bold: P < 0.05; a, Mann-Whitney Test; Exp, Experience; PHQ, Patient Health Questionnaire; GAD, Generalized Anxiety Disorder 7-item scale; FCR, Fear of
Cancer Recurrence.
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TABLE 2 | Multivariate logistic regression of factors associated with high fear of
cancer recurrence.





Age ≤39 years Ref – – –
40–60 years 0.867 0.592 1.269 0.462
≥60 yeaers 1.022 0.608 1.718 0.935
Gender (female) 1.292 0.756 2.207 0.348
Marital status Single Ref
Married 0.722 0.374 1.393 0.331
Divorced 0.606 0.235 1.566 0.301





Ref – – –
3,000–5,000 RMB 0.768 0.525 1.125 0.175
5,000–10,000 RMB 0.819 0.453 1.481 0.509
More than 10,000
RMB
0.592 0.377 0.931 0.023
Education level High school Ref – – –
Undergraduate 1.234 0.832 1.830 0.297
Postgraduate 0.860 0.488 1.515 0.601
Chemotherapy 1.941 1.189 3.170 0.008
Childhood severe
illness exp
2.802 1.287 6.101 0.009
Depression (PHQ
score)
1.153 1.081 1.230 <0.001
Anxiety (GAD score) 1.249 1.155 1.351 <0.001
CI, Confidence Interval; in bold: P < 0.05; Exp, Experience; PHQ, Patient Health
Questionnaire; GAD, Generalized Anxiety Disorder 7-item scale; FCR, Fear of
Cancer Recurrence; Ref, Reference Category.
in comparison with their counterparts. In terms of monthly
income, patients with higher income were less likely to report
high FCR (Table 1).
Multivariate Logistic Regression
Analyses
Multivariate logistic regression analyses showed that the receipt
of chemotherapy (OR = 1.941, P = 0.008), childhood severe illness
experience (OR = 2.802, P = 0.009), depressive (OR = 1.153,
P < 0.001) and anxiety symptoms (OR = 1.249, P < 0.001)
were positively associated with high FCR, while higher monthly
income (more than 10,000 RMB, OR = 0.592, P = 0.023) was
negative associated with high FCR (Table 2).
Structural Equation Modeling (SEM)
The results of spearman correlation analyses are shown in
Table 3. Monthly income was negatively associated with
depression (r = -0.170), anxiety (r = -0.125) and FCR total score
(r = -0.136, P all P < 0.001). Chemotherapy and childhood
severe illness experience showed no significant association with
depression and anxiety score, and only weak association with
FCR total score, which indicated that these two variables were
not satisfactory to perform SEM (Yan et al., 2019; Zhang
et al., 2020). Therefore, in the current study, only model of
monthly income on FCR by emotional disturbances (anxiety and
depression) was conducted.
TABLE 3 | Key variables and Spearman correlation coefficients.










−0.170*** 0.024 0.024 1
5. GAD total
score
−0.125*** −0.002 0.013 0.773*** 1
6. FCR total
score
−0.136*** 0.093** 0.066* 0.517*** 0.544*** 1
*P < 0.05, **P < 0.01, ***P < 0.001. PHQ, Patient Health Questionnaire; GAD,
Generalized Anxiety Disorder 7-item scale; FCR, Fear of Cancer Recurrence.
Figure 2 presents the model of monthly income on
FCR by emotional disturbances (anxiety and depressive
symptoms). Results of SEM indicated that the model had
a decent fit (χ2/df = 7.979, CFI = 0.981, NFI = 0.979,
IFI = 0.981, TLI = 0.953, RMSEA = 0.080) after controlling
for age. Emotional disturbances directly influenced FCR. The
standardized total effect of emotional disturbances on FCR was
0.596 (P < 0.05). Monthly income did not directly influence
FCR, however, emotional disturbances partly mediated the
association between personal monthly income and FCR. The
standardized total effect of monthly income on FCR was -0.122
(standardized direct effect = -0.021, P > 0.05; standardized
indirect effect = −0.101, P < 0.05).
DISCUSSION
In the current study, nearly 65% of the newly diagnosed cancer
patients reported high FCR. One longitudinal study in 2013
reported that the prevalence rate of clinically significant FCR
ranged from 44 to 56% during the cancer care trajectory, with
the highest levels at a per-operative baseline, but persisting over
time (Savard and Ivers, 2013). A recent study using the same
assessment tool revealed that only 17% of the cancer patients
reported high FCR (Gotze et al., 2019), and a similar study
among young Chinese cancer population indicated that the
prevalence of high FCR was around 36% (Sun et al., 2019).
Cancer diagnosis and treatment is a key period of transition
with important physical as well as emotional changes. For some
patients, cancer diagnosis is even considered as a traumatic
event capable of producing symptoms consistent with Post-
traumatic stress disorder (PTSD) (Simonelli et al., 2017). The
distressing symptoms experienced by newly diagnosed patients
are often underreported and inadequately addressed by treating
oncologists (Ghoshal et al., 2016). More supportive interventions
are needed to improve the health care and quality of life
for those patients.
Consistent with our first hypothesis, our study showed that
patients with depression and anxiety had a higher probability to
experience high levels of FCR. Literature supports the finding
that there is a moderate positive association between FCR
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FIGURE 2 | Model of monthly income on FCR by emotional disturbances. ***P < 0.001.
and generalized anxiety, hypochondriasis, depression, symptom
distress, and psychological functioning (Chaturvedi et al., 1996;
Humphris et al., 2003; Llewellyn et al., 2008; Thewes et al.,
2013). Patients who experience FCR often report the chaining
characteristics of worry. Those patients are more likely to spend
time thinking about their disease and the risk of recurrence
or progression, and they tend to have poorer psychosocial
adjustment (Pedersen et al., 2012). This pattern may impair
appraisal of coping responses and contribute to maintenance of
fear (Simonelli et al., 2017).
The second hypothesis of the current study was partly
confirmed by our study results. The association between
personal monthly income and FCR was significantly mediated
by emotional disturbances. Several previous findings indicated
that those who were unemployed (without stable income) and
those who were under great financial burdens were more likely to
experience increased FCR (Skaali et al., 2009; Yang et al., 2018).
However, contradictory results were also reported (Simard et al.,
2013). Additionally, it has also been reported that depressive
symptoms could arise as a common consequence of stress, and
financial burden is considered as one important stressful live
event (Halada et al., 2019). This could be a potential reason to
explain the interaction between income and FCR.
Consistent with previous meta-analysis (Yang et al., 2017),
chemotherapy was found to have a significant association
with FCR. Patients who had been through chemotherapy may
experience various side effects such as, nausea and vomiting,
loss of hair, fatigue, endocrine dysfunction, and infertility
(Yang et al., 2017). It has been reported that those symptoms
serve as a reminder of the cancer therefore can significantly
contribute to higher levels of FCR (Mehnert et al., 2009).
Previous studies also showed that patients with chemotherapy
are at higher risk of experience emotional distress, such as,
anxiety, depression and insomnia symptoms (NHS, 2020).
However, the current study found no significant association
between chemotherapy and emotional disturbances. One possible
reason is that more recently, patients consider chemotherapy
as a neutral routine treatment and have made substantial
preparation to cope with it. Health professionals also are
improving their provision of information and psychosocial
support for those in need.
Similarly, childhood severe illness experience was significantly
associated with FCR. Evidence was found that patients with
previous illness history are more likely to experience uncertainty
about their future, PTSD and maladaptation (Dolgin et al., 1999).
Therefore, they are at higher risk of developing FCR (Yang et al.,
2018). However, the link between past illness experience and
FCR should be interpreted with caution as only very few studies
investigated this association in detail.
Our study findings confirmed our third hypothesis
that compared to sociodemographic/clinical variables,
psychological/emotional variables had greater total effect
on FCR. One previous study indicated that sociodemographic
and clinical variables only accounted for 7.2% of the variance
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in FCR, while the addition of psychological factors (anxiety,
depression, and personality) increased the explained variance by
32.8% (Yang et al., 2018). Another study reported that anxiety,
post-traumatic stress and functional and emotional well-being
accounted for over 40% of variance in FCR (Urbaniec et al.,
2011). Influential theoretical models of FCR, such as Leventhal’s
Common Sense Model (CSM) (Leventhal et al., 1992; Lee-Jones
et al., 1997) and cognitive theories of worry (Dugas et al.,
1998), suggested that FCR shares similarities to anxiety and
depressive symptoms, as patients frequently report low tolerance
for uncertainty and limited future planning.
The present study has several limitations. First, several
important variables, such as perceived family and social support
were not investigated. Further studies are needed to explore the
influence of these factors on FCR. Second, this was a cross-
sectional study which could not draw any causal association
between tested variables and FCR. Longitudinal studies are
needed to further identify the causal association and monitor
the trajectory of FCR. Third, all results were based on self-
reported data, and thus recall bias may exist. Finally, some
of the tested variables have floor effects, such as, the majority
of the participants were females, married, and had received
chemotherapy. The maldistribution of sample might cause bias,
therefore, the findings cannot be generalized to the entire Chinese
cancer population. Further studies with more representative
samples using validated objective instruments are warranted.
This study provides several points of interest. Our study
showed that high FCR is a frequently reported problem
among newly diagnosed cancer population. Patient’s monthly
income, the receipt of chemotherapy, childhood severe illness
experience, and emotional disturbances (anxiety and depression)
significantly influenced FCR. Emotional disturbances partly
mediated the association between personal monthly income and
FCR. These results imply that patients with these characteristics
should be particularly monitored and timely psychological
support should be provided when necessary.
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